DUBLIN, Sept. 17, 2018 /PRNewswire/ --
The "Blood Pressure Disorders Drug Development Pipeline Review, 2018"report has been added to ResearchAndMarkets.com's offering.
This report Blood Pressure Disorders Drug Development Pipeline Review, 2018 provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive
Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. Many factors can affect blood pressure, including hormone levels, water and salt levels in the body and the condition of the kidneys, nervous system, and blood vessels.Most people with high blood pressure have no signs or symptoms, even if blood pressure readings reach dangerously high levels. Although a few people with early-stage high blood pressure may have dull headaches, dizzy spells or a few more nosebleeds than normal, these signs and symptoms typically do not occur until high blood pressure has reached a severe stage. There are 253 products in development for this indication. PAH is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema). There are 92 products in development for this indication. Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness and weakness. Pipeline activity is much lower for hypotension than for hypertension or PAH with only seven products in development for this indication.
Molecular targets acted on by products in development for blood pressure disorders include angiotensin receptors, tyrosine protein kinases and phosphodiesterases.
Reasons to buy
Key Topics Covered:
1 Tables & Figures2 Introduction2.1 Blood Pressure Disorder Report Coverage2.2 Hypertension - Overview2.3 Hypotension - Overview2.4 Pulmonary Arterial Hypertension - Overview3 Therapeutics Development3.1 Hypertension3.2 Hypotension3.3 Pulmonary Arterial Hypertension4 Therapeutics Assessment4.1 Hypertension4.2 Hypotension4.3 Pulmonary Arterial Hypertension5 Companies Involved in Therapeutics Development5.1 Hypertension5.2 Hypotension 5.3 Pulmonary Arterial Hypertension 6 Dormant Projects 6.1 Hypertension 6.2 Hypotension 6.3 Pulmonary Arterial Hypertension 7 Discontinued Products 7.1 Hypertension 7.2 Pulmonary Arterial Hypertension 8 Product Development Milestones 8.1 Hypertension 8.2 Hypotension 8.3 Pulmonary Arterial Hypertension
For more information about this report visit https://www.researchandmarkets.com/research/mnzckt/blood_pressure?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/blood-pressure-disorders-drug-development-pipeline-review-2018---molecule-type-molecular-target-mechanism-of-action-and-route-of-administration-300713720.html
SOURCE Research and Markets
Subscribe to our Free Newsletters!
Bad eating habits will affect your health as well as your skin and make you look older than your ...
A lump in the armpit can be due to a benign infection, allergy or fatty tissue growth. It is ...
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...View All